Tanja Obradovic, Vice President, Medical and Scientific Strategy, Oncology at Novotech, shared Novotech’s post on LinkedIn, adding:
“Few more days to register for free webinar ‘The Role of APAC in Global Oncology Development‘.
We just finished ESMO 2026.
Outstanding summary of Presidential Sessions by OncoDaily where several China-only PhIII trials were reported (ESMO 2026 Presidential Symposia: From Trial Results to Clinical Implications – OncoDaily).
Incoming webinar is excellent opportunity to discuss current and future state of APAC-originated innovation in clinical oncology and what future holds for advancing global patient access.
Register for free webinar: The Role of APAC in Global Oncology Development.”
Quoting Novotech’s post:
“Where does APAC add the most value in global oncology development?
For sponsors, the answer depends on which markets fit their program, when to involve them, and how they support the broader development strategy.
Join industry experts for a discussion exploring how early strategic decisions around market selection and regulatory pathways can help position an oncology program for global development.
November 3 | 1 PM PT.”
Other articles from Tanja Obradovic on OncoDaily.